NOVUS Life Sciences Limited, founded in 2014 and headquartered in Hong Kong, is a global biomaterials R&D and manufacturing company specializing in medical-grade 3D printing materials and solutions for implants, surgical guides, dental applications, and regenerative medicine.

With advanced manufacturing and technical capabilities in Hong Kong and Shenzhen, NOVUS develops and manufactures ISO 13485-certified polymer filaments, including PEEK, PLLA, PETG, PC, PMMA, as well as nano-composites and resorbable polymer composites engineered for hard- and soft-tissue regeneration. Our proprietary bioactive material, Bonlecule®, is designed to enhance biological performance in additively manufactured implants and regenerative applications.

Beyond materials supply, NOVUS provides end-to-end technical and regulatory support, including material development, process validation, and medical 3D printing production line setup, enabling partners to translate advanced biomaterials into regulated, real-world clinical use.

Today, NOVUS supports 150+ clients across 50+ countries, including hospitals, research institutes, manufacturers, and industry partners, working together to advance innovation in medical additive manufacturing and regenerative medicine.

#Medical3DPrinting #Biomaterials #RegenerativeMedicine #NanoComposites #MedicalInnovation #NOVUSLifeSciences

Novus Life Sciences Limited

Org chart

Teams

Offices

Novus Life Sciences Limited

Org chart

Teams

Offices

Related companies